October 2007 |
Karus scientist presents at key industry conferences (DOC 32KB) |
October 2007 |
Novel synthetic analogues of the natural product histone deacetylase inhibitor FK228 (PDF 91KB) |
October 2006 |
Drummond Paris named as Chairman of Karus Therapeutics (PDF 86KB) |
May 2006 |
Karus Therapeutics appoints Simon Kerry as CEO (PDF 60KB) |
December 2005 |
Collaboration with Sareum Holdings (PDF 73KB) |
July 2005 |
(PDF 56KB) |
![]()
Yurek-George, et al |
The first biologically active synthetic analogues of FK228, the depsipeptide histone deacetylase inhibitor; J Med Chem; 2007 (PDF 126KB) |
Yurek-George, et al |
Total synthesis of Spiruchostatin A, a potent histone deacetylase inhibitor; J Am Chem Soc; 2004 (PDF 64KB) |
Davidson, et al |
The transcriptional coactivator p300 plays a critical role in the hypertrophic and protective pathways induced by phenylephrine in cardiac cells…; Chem Biochem; 2005 (PDF 238KB) |
Karus Therapeutics Ltd
John Fairclough Centre
University of Southampton
Highfield
Southampton
Hampshire SO17 1BJ
United Kingdom